glp 1 agonist in heart failure GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms GLP-1 agonists for heart failure:
Description
What are the common side effects
Successful behavior change in obesity interventions in adults: a systematic review of self-regulation mediators
Hepatol Res 47(10):10721078
These drugs are both dopamine and cholinergic receptor antagonists that act on the area postrema in the brainstem
Hopefully before the end of the year we will have additional data from the lixisenatide and PT320 Phase II studies which will add to our knowledge of this drug class in Parkinsons
